Cardiovascular consequences of discontinuing low-dose rivaroxaban in people with chronic coronary or peripheral artery disease. - Dagenais GR; Dyal L; Bosch JJ; Leong DP; Aboyans V; Berkowitz SD; Bhatt DL; Connolly SJ; Fox KAA; Muehlhofer E; Probstfield JL; Widimsky P; et al. (Heart (British Cardiac Society), 2021)